正川股份收盘上涨1.71%，滚动市盈率60.53倍，总市值26.10亿元

Group 1 - The core viewpoint of the news is that Zhengchuan Co., Ltd. has seen a decline in its financial performance, with a significant drop in both revenue and net profit in the first quarter of 2025 compared to the previous year [1] - As of May 8, the closing price of Zhengchuan Co., Ltd. was 17.26 yuan, reflecting a 1.71% increase, with a rolling PE ratio of 60.53, marking a new low in 22 days [1] - The total market capitalization of Zhengchuan Co., Ltd. is 2.61 billion yuan, and it ranks 93rd in the medical device industry based on PE ratio, which has an average of 49.20 and a median of 36.56 [1][2] Group 2 - The company specializes in the research, production, and sales of pharmaceutical packaging materials, including borosilicate glass vials and sodium-calcium glass vials [1] - As of the first quarter of 2025, two institutions hold shares in Zhengchuan Co., Ltd., with a total of 59.40 million shares valued at 1.03 billion yuan [1] - The latest financial results show that the company achieved an operating income of 162 million yuan, a year-on-year decrease of 34.24%, and a net profit of 10.91 million yuan, down 48.15% year-on-year, with a gross profit margin of 21.61% [1]